应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
WST West Pharmaceutical Services Inc
交易中 11-03 11:14:47 EST
412.98
+5.10
+1.25%
最高
416.23
最低
406.05
成交量
29.60万
今开
407.42
昨收
407.88
日振幅
2.50%
总市值
287.69亿
流通市值
285.51亿
总股本
6,966万
成交额
1.22亿
换手率
0.43%
流通股本
6,913万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读|West Pharmaceutical Services Inc盘中上涨5.18%,三季度业绩超预期并上调全年指引
行情直击 · 10-29
异动解读|West Pharmaceutical Services Inc盘中上涨5.18%,三季度业绩超预期并上调全年指引
财报前瞻 | West Pharmaceutical Services Inc本季度营收预计增4.79%,机构观点偏多
财报Agent · 10-22
财报前瞻 | West Pharmaceutical Services Inc本季度营收预计增4.79%,机构观点偏多
异动解读|西制药服务公司盘中下跌5.41%,财报大超预期后回吐前日涨幅
行情直击 · 07-25
异动解读|西制药服务公司盘中下跌5.41%,财报大超预期后回吐前日涨幅
西氏医药(WST)二季度调整后稀释每股收益达2.37美元 同比大增28.8%
金吾财讯 · 07-23
西氏医药(WST)二季度调整后稀释每股收益达2.37美元 同比大增28.8%
异动解读 | 西制药服务公司盘前大涨6.02%,因上调年度预期及注射药物需求强劲
异动解读 · 07-23
异动解读 | 西制药服务公司盘前大涨6.02%,因上调年度预期及注射药物需求强劲
财报前瞻|West Pharmaceutical Services Inc本季度营收预计同比增15.24%,机构观点偏多
财报Agent · 07-16
财报前瞻|West Pharmaceutical Services Inc本季度营收预计同比增15.24%,机构观点偏多
West Pharmaceutical Services协议期限十年 经双方同意或控制权变更可提前终止 - SEC文件披露
美股速递 · 07-15
West Pharmaceutical Services协议期限十年 经双方同意或控制权变更可提前终止 - SEC文件披露
West Pharmaceutical Services Inc与Daikyo Seiko修订交叉许可与分销协议,2026年7月14日生效
美股速递 · 07-15
West Pharmaceutical Services Inc与Daikyo Seiko修订交叉许可与分销协议,2026年7月14日生效
West Pharmaceutical Services 达成协议 涵盖药品包装产品联合开发与专有技术共享
美股速递 · 07-15
West Pharmaceutical Services 达成协议 涵盖药品包装产品联合开发与专有技术共享
巴克莱将West Pharmaceutical Services Inc评级上调至超配,目标价提至400美元
美股速递 · 06-10
巴克莱将West Pharmaceutical Services Inc评级上调至超配,目标价提至400美元
West Pharmaceutical Services核心企业系统已恢复 所有工厂在遭遇网络攻击后重启生产、收货与发货
美股速递 · 05-21
West Pharmaceutical Services核心企业系统已恢复 所有工厂在遭遇网络攻击后重启生产、收货与发货
West Pharmaceutical旗下HVP站点、标准包装站点及HVP给药装置站点全面恢复收发货运营
美股速递 · 05-16
West Pharmaceutical旗下HVP站点、标准包装站点及HVP给药装置站点全面恢复收发货运营
West Pharmaceutical Services:多数West Vantage站点已投入运营,关键收发流程就绪,生产正加速推进
美股速递 · 05-16
West Pharmaceutical Services:多数West Vantage站点已投入运营,关键收发流程就绪,生产正加速推进
West Pharmaceutical Services:全球业务恢复取得显著进展,网络攻击后运营逐步回归正轨
美股速递 · 05-16
West Pharmaceutical Services:全球业务恢复取得显著进展,网络攻击后运营逐步回归正轨
一周美股牛股 | 伊瑞保险、Fair Isaac涨超11%;West Pharmaceutical涨10%;Solventum涨9%;财捷涨8%;美国电塔涨7%
老虎资讯综合 · 2025-03-03
一周美股牛股 | 伊瑞保险、Fair Isaac涨超11%;West Pharmaceutical涨10%;Solventum涨9%;财捷涨8%;美国电塔涨7%
Keybanc:维持West Pharmaceutical Servs(WST.US)评级,由增持调整至增持评级, 目标价由470.00美元调整至325.00美元。
金融界 · 2025-02-15
Keybanc:维持West Pharmaceutical Servs(WST.US)评级,由增持调整至增持评级, 目标价由470.00美元调整至325.00美元。
West Pharmaceutical Services, Inc.涨3.62% 股价突破200美元大关
市场透视 · 2025-02-14
West Pharmaceutical Services, Inc.涨3.62% 股价突破200美元大关
异动解读 | 西药公司2025年业绩预期大跌,股价盘中暴跌23%
异动解读 · 2025-02-13
异动解读 | 西药公司2025年业绩预期大跌,股价盘中暴跌23%
West Pharmaceutical Services, Inc.盘中异动 急速下挫23.98%
市场透视 · 2025-02-13
West Pharmaceutical Services, Inc.盘中异动 急速下挫23.98%
异动解读 | 西药公司业绩预期大失所望,股价暴跌近20%
异动解读 · 2025-02-13
异动解读 | 西药公司业绩预期大失所望,股价暴跌近20%
加载更多
公司概况
公司名称:
West Pharmaceutical Services Inc
所属市场:
NYSE
上市日期:
--
主营业务:
West Pharmaceutical Services, Inc.根据宾夕法尼亚州的法律于1923年7月27日成立。该公司是设计和生产技术先进,高质量,集成化的用于注射药物和保健产品的密封和输送系统的全球领先制造商。该公司的产品包括各种初级包装,容纳解决方案,重构和转移系统,药物输送系统,以及合同制造,分析实验室服务和集成解决方案。
发行价格:
--
{"stockData":{"symbol":"WST","market":"US","secType":"STK","nameCN":"West Pharmaceutical Services Inc","latestPrice":412.98,"timestamp":1793722481955,"preClose":407.88,"halted":0,"volume":295991,"delay":0,"changeRate":0.012503677552221298,"floatShares":69134400,"shares":69661000,"eps":8.903189,"marketStatus":"交易中","change":5.1,"latestTime":"11-03 11:14:47 EST","open":407.42,"high":416.23,"low":406.05,"amount":121957686.75434001,"amplitude":0.024958,"askPrice":413.32,"askSize":122,"bidPrice":412.87,"bidSize":10,"shortable":3,"etf":0,"ttmEps":8.903189,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1793739600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":391752000000,"exchange":"NYSE","adjPreClose":407.88,"dividendRate":0.002131,"preHourTrading":{"tag":"盘前","latestPrice":408,"preClose":407.88,"latestTime":"09:23 EST","volume":85,"amount":34759.19195,"timestamp":1793715817861,"change":0.12,"changeRate":0.000294,"amplitude":0.063725},"postHourTrading":{"tag":"盘后","latestPrice":410,"preClose":407.88,"latestTime":"19:34 EST","volume":41975,"amount":17120732.9151,"timestamp":1793666080751,"change":2.12,"changeRate":0.005198,"amplitude":0.006203},"volumeRatio":0.922853,"impliedVol":0.2765,"impliedVolPercentile":0.2151},"requestUrl":"/m/hq/s/WST","defaultTab":"news","newsList":[{"id":"1113644629","title":"异动解读|West Pharmaceutical Services Inc盘中上涨5.18%,三季度业绩超预期并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1113644629","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113644629?lang=zh_cn&edition=full","pubTime":"2026-10-29 21:31","pubTimestamp":1793280718,"startTime":"0","endTime":"0","summary":"10月29日,West Pharmaceutical Services Inc盘中上涨5.18%,报428.4美元,成交额1984.16万美元。消息面上,公司披露三季度调整后每股收益2.66美元,高于市场预期的2.20美元,上年同期为1.96美元;季度销售额8.745亿美元,高于预期的8.271亿美元,上年同期为8.046亿美元。同时,公司将全年调整后每股收益指引上调至9.38至9.48美元,前值为8.85至9.05美元;全年销售额预期上调至34.1亿至34.2亿美元,也高于市场预期的33.8亿美元。业绩与指引双双上修,成为股价走强的直接催化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"业绩超预期并上调全年指引,股价强势上涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177366966","title":"财报前瞻 | West Pharmaceutical Services Inc本季度营收预计增4.79%,机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1177366966","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177366966?lang=zh_cn&edition=full","pubTime":"2026-10-22 10:21","pubTimestamp":1792635685,"startTime":"0","endTime":"0","summary":"West Pharmaceutical Services Inc将于2026年10月29日发布新季度财报,市场预期营收温和增长、盈利韧性延续,关注产品结构与定价带来的利润弹性。根据市场一致预期,本季度West Pharmaceutical Services Inc营收为8.26亿美元,同比增长4.79%;调整后每股收益为2.19美元,同比增长30.38%;市场亦预测EBIT为1.86亿美元,同比增长26.59%;关于本季度毛利率、净利润或净利率的共识数据未在当前数据集中披露。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | West Pharmaceutical Services Inc本季度营收预计增4.79%,机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197383307","title":"异动解读|西制药服务公司盘中下跌5.41%,财报大超预期后回吐前日涨幅","url":"https://stock-news.laohu8.com/highlight/detail?id=1197383307","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197383307?lang=zh_cn&edition=full","pubTime":"2026-07-25 00:00","pubTimestamp":1784908809,"startTime":"0","endTime":"0","summary":"7月24日,West Pharmaceutical Services盘中下跌5.41%,报336.26美元/股,成交额1.35亿美元。公司同步将全年调整后EPS指引上调至8.85–9.05美元,高于此前的8.40–8.75美元及市场预期的8.62美元。财报发布后股价曾盘前大涨逾6%。7月24日当天,Jefferies、德意志银行分别将目标价上调至410美元、420美元并维持买入评级,但股价仍回吐前日大部分涨幅,呈现典型的利好兑现后回调走势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653742306","title":"西氏医药(WST)二季度调整后稀释每股收益达2.37美元 同比大增28.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653742306","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653742306?lang=zh_cn&edition=full","pubTime":"2026-07-23 19:20","pubTimestamp":1784805600,"startTime":"0","endTime":"0","summary":"稀释后每股收益增至 2.15 美元;调整后稀释每股收益达 2.37 美元,同比大幅增长 28.8%。HVP 给药装置销售额大幅增长 29.6% 至 1.312 亿美元,占总营收的 15%。西氏优势业务二季度实现净销售额 1.497 亿美元,同比微增 2.0%,有机增长 0.8%。全年调整后每股收益从8.40–8.75 美元,上调至 8.85–9.05 美元。同时,预计 2026 年第三季度净销售额在 8.20 亿–8.35 亿美元之间,有机增长 7.0%–8.9%,调整后稀释 EPS 预计为 2.14–2.24 美元。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/YmI1NjBhYTU5MWI5ZWU1NjUzMTczNjIzMDkxNzMzMg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YmI1NjBhYTU5MWI5ZWU1NjUzMTczNjIzMDkxNzMzMg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302948","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1515","BK1574","BK4588","BK4567","BK1161","BK4504","BK4121","IE00BFXG0V08.USD","LU0106261612.USD","09939","BK4585","IE00B64QTZ34.USD","IE00BYQQ9H92.USD","LU0012050646.USD","UDN","LU0345774391.USD","WST","UUP","LU0345774631.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132704992","title":"异动解读 | 西制药服务公司盘前大涨6.02%,因上调年度预期及注射药物需求强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=1132704992","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132704992?lang=zh_cn&edition=full","pubTime":"2026-07-23 19:03","pubTimestamp":1784804605,"startTime":"0","endTime":"0","summary":"西制药服务公司今日盘前股价大涨6.02%,引起了市场的广泛关注。消息面上,该公司上调了2026年度的利润和营收预期,同时第二季度业绩超出市场预期。公司预计2026年经调整后每股收益将在8.85美元至9.05美元之间,高于此前预期的8.40美元至8.75美元;年度销售额预计在33.5亿美元至33.8亿美元之间,也高于此前预测区间。西制药服务公司生产用于包装和给药的疫苗、生物制剂及其他注射剂的组件,因此直接受益于此趋势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175063924","title":"财报前瞻|West Pharmaceutical Services Inc本季度营收预计同比增15.24%,机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1175063924","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175063924?lang=zh_cn&edition=full","pubTime":"2026-07-16 09:13","pubTimestamp":1784164412,"startTime":"0","endTime":"0","summary":"West Pharmaceutical Services Inc将于2026年07月23日发布财报,市场聚焦收入增长与利润率修复节奏。市场一致预期本季度West Pharmaceutical Services Inc营收为8.38亿美元,同比增长15.24%;调整后每股收益为2.08美元,同比增长37.84%;息税前利润为1.78亿美元,同比增长32.61%。多家机构对West Pharmaceutical Services Inc本季度持偏多观点,认为收入与利润有望实现两位数增长,看多比例占优。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻|West Pharmaceutical Services Inc本季度营收预计同比增15.24%,机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144695311","title":"West Pharmaceutical Services协议期限十年 经双方同意或控制权变更可提前终止 - SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1144695311","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144695311?lang=zh_cn&edition=full","pubTime":"2026-07-15 04:35","pubTimestamp":1784061353,"startTime":"0","endTime":"0","summary":"根据向美国证券交易委员会(SEC)提交的文件,West Pharmaceutical Services Inc.披露了其相关协议的条款细节。文件显示,该等协议设定了为期十年的初始期限。\n值得注意的是,协议中包含提前终止条款。在两种特定情况下,协议可在十年期满前终止:一是经签约双方共同协商同意;二是发生公司控制权变更的情形。\n此项披露为投资者提供了关于该公司长期合约安排稳定性的进一步信息,明确了可能影响协议持续性的关键条件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFXG0V08.USD","BK4585","IE00BYQQ9H92.USD","BK4121","BK4567","LU0012050646.USD","LU0345774391.USD","WST","LU0106261612.USD","LU0345774631.USD","BK4588","IE00B64QTZ34.USD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170457502","title":"West Pharmaceutical Services Inc与Daikyo Seiko修订交叉许可与分销协议,2026年7月14日生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1170457502","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170457502?lang=zh_cn&edition=full","pubTime":"2026-07-15 04:33","pubTimestamp":1784061195,"startTime":"0","endTime":"0","summary":"West Pharmaceutical Services Inc与Daikyo Seiko已签署修订后的交叉许可及分销协议,该协议将于2026年7月14日正式生效。此次修订旨在优化双方的合作框架,进一步明确各自的权利与义务。\n根据协议内容,双方将继续在特定市场领域深化合作,共享技术资源并扩大产品分销网络。这一举措有望增强两家公司在全球医药包装市场的竞争力,并为未来的业务拓展奠定更稳固的基础。\n协议的修订细节已按规定向美国证券交易委员会提交备案。此举标志着双方长期战略伙伴关系进入了新的阶段,预计将对相关业务线的运营效率与市场协同产生积极影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345774631.USD","LU0345774391.USD","BK4567","BK4121","BK4588","BK4504","LU0106261612.USD","IE00BYQQ9H92.USD","IE00BFXG0V08.USD","BK4585","WST","LU0012050646.USD","IE00B64QTZ34.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136443563","title":"West Pharmaceutical Services 达成协议 涵盖药品包装产品联合开发与专有技术共享","url":"https://stock-news.laohu8.com/highlight/detail?id=1136443563","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136443563?lang=zh_cn&edition=full","pubTime":"2026-07-15 04:33","pubTimestamp":1784061192,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会的文件,West Pharmaceutical Services Inc 已签署一项协议,内容涉及药品包装产品的联合开发与专有技术共享。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFXG0V08.USD","LU0012050646.USD","BK4567","BK4504","LU0106261612.USD","LU0345774391.USD","BK4121","BK4588","LU0345774631.USD","IE00BYQQ9H92.USD","BK4585","IE00B64QTZ34.USD","WST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187679080","title":"巴克莱将West Pharmaceutical Services Inc评级上调至超配,目标价提至400美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187679080","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187679080?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:22","pubTimestamp":1781086936,"startTime":"0","endTime":"0","summary":"巴克莱银行将West Pharmaceutical Services Inc的股票评级从“均配”上调至“超配”,同时将其目标股价从310美元大幅提升至400美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","IE00B64QTZ34.USD","IE00BYQQ9H92.USD","LU0345774391.USD","LU0345774631.USD","IE00BFXG0V08.USD","LU0012050646.USD","WST","LU0106261612.USD","BK4585","BK4504","BK4567","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133725685","title":"West Pharmaceutical Services核心企业系统已恢复 所有工厂在遭遇网络攻击后重启生产、收货与发货","url":"https://stock-news.laohu8.com/highlight/detail?id=1133725685","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133725685?lang=zh_cn&edition=full","pubTime":"2026-05-21 04:32","pubTimestamp":1779309134,"startTime":"0","endTime":"0","summary":"在经历网络攻击后,West Pharmaceutical Services Inc已成功恢复其核心企业系统的运行。目前,公司旗下所有工厂的生产、收货及发货业务均已全面重启。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345774631.USD","WST","LU0012050646.USD","LU0345774391.USD","BK4567","BK4504","IE00B64QTZ34.USD","IE00BFXG0V08.USD","LU0106261612.USD","IE00BYQQ9H92.USD","BK4585","BK4588","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137825018","title":"West Pharmaceutical旗下HVP站点、标准包装站点及HVP给药装置站点全面恢复收发货运营","url":"https://stock-news.laohu8.com/highlight/detail?id=1137825018","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137825018?lang=zh_cn&edition=full","pubTime":"2026-05-16 01:20","pubTimestamp":1778865620,"startTime":"0","endTime":"0","summary":"West Pharmaceutical Services Inc宣布,其高价值产品(HVP)站点、标准包装站点以及HVP给药装置站点现已全面恢复收发货运营。所有相关设施均已恢复正常运作,能够处理客户订单的接收与发运。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261612.USD","LU0345774631.USD","WST","IE00BFXG0V08.USD","BK4121","BK4567","IE00BYQQ9H92.USD","IE00B64QTZ34.USD","BK4585","LU0012050646.USD","LU0345774391.USD","BK4588","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154399045","title":"West Pharmaceutical Services:多数West Vantage站点已投入运营,关键收发流程就绪,生产正加速推进","url":"https://stock-news.laohu8.com/highlight/detail?id=1154399045","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154399045?lang=zh_cn&edition=full","pubTime":"2026-05-16 01:17","pubTimestamp":1778865474,"startTime":"0","endTime":"0","summary":"West Pharmaceutical Services宣布,其大部分West Vantage站点现已投入运营,关键的发货与接收流程已准备就绪,同时生产活动正在加速推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","BK4588","IE00B64QTZ34.USD","BK4504","IE00BYQQ9H92.USD","LU0012050646.USD","LU0345774391.USD","BK4121","LU0345774631.USD","IE00BFXG0V08.USD","BK4585","WST","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190535433","title":"West Pharmaceutical Services:全球业务恢复取得显著进展,网络攻击后运营逐步回归正轨","url":"https://stock-news.laohu8.com/highlight/detail?id=1190535433","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190535433?lang=zh_cn&edition=full","pubTime":"2026-05-16 01:16","pubTimestamp":1778865382,"startTime":"0","endTime":"0","summary":"West Pharmaceutical Services Inc 近日宣布,在应对全球范围内的网络攻击事件后,公司在恢复运营方面持续取得重大进展。目前,各项业务正稳步回归正轨,系统与服务的恢复工作正按计划推进。\n公司表示,其团队正全力以赴,以安全、可控的方式逐步重启全球运营。此次恢复进程涵盖了关键业务环节,旨在最小化对客户及合作伙伴的影响。\n尽管面临挑战,West Pharmaceutical Services 强调其致力于保障供应链的完整性与产品交付的可靠性。公司将继续向利益相关方通报最新情况,并采取一切必要措施强化其网络安全防护体系。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WST","BK4504","IE00BFXG0V08.USD","LU0106261612.USD","BK4121","BK4585","BK4588","IE00BYQQ9H92.USD","LU0345774391.USD","BK4567","LU0345774631.USD","IE00B64QTZ34.USD","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113034171","title":"一周美股牛股 | 伊瑞保险、Fair Isaac涨超11%;West Pharmaceutical涨10%;Solventum涨9%;财捷涨8%;美国电塔涨7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113034171","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113034171?lang=zh_cn&edition=full","pubTime":"2025-03-03 10:37","pubTimestamp":1740969431,"startTime":"0","endTime":"0","summary":"上周伊瑞保险股价上涨11.6%。伊瑞保险表示,其保单签发与续期服务的管理费收入在2024年同比增长4.52亿美元,第四季度同比增加9670万美元。$Fair Isaac Corp$ Q1业绩强劲,股价飙升11%上上周,Fair Isaac宣布与与肯尼亚 TransUnion 合作推出新的信用风险解决方案,以提升金融普惠性。加之公司近期更新股票回购计划并给出乐观财年指引,投资者热情高涨,推动其股价上周上涨11.09%。","market":"us","thumbnail":"https://community-static.tradeup.com/news/fd176bd3635d0bbb104ba2e21f7080af","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/fd176bd3635d0bbb104ba2e21f7080af"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"一周美股牛股 | 伊瑞保险、Fair Isaac涨超11%;West Pharmaceutical涨10%;Solventum涨9%;财捷涨8%;美...","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERIE","INTU","AIG","FICO","SOLV","TRV","AMT","RTX","WST","CINF"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2511133286","title":"Keybanc:维持West Pharmaceutical Servs(WST.US)评级,由增持调整至增持评级, 目标价由470.00美元调整至325.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511133286","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511133286?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:33","pubTimestamp":1739554413,"startTime":"0","endTime":"0","summary":"Keybanc:维持West Pharmaceutical Servs(WST.US)评级,由增持调整至增持评级, 目标价由470.00美元调整至325.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/15013348179357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["WST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511699532","title":"West Pharmaceutical Services, Inc.涨3.62% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2511699532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511699532?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:33","pubTimestamp":1739543595,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时33分,West Pharmaceutical Services, Inc.股票出现异动,股价大幅拉升3.62%。West Pharmaceutical Services, Inc.股票所在的医疗设备行业中,整体涨幅为0.36%。其相关个股中,West Pharmaceutical Services, Inc.、Staar Surgical Company、Azenta, Inc.涨幅较大,Avinger, Inc.、Sharps Technology Inc.、Microbot Medical Inc.较为活跃,换手率分别为13.57%、1.69%、1.51%,振幅较大的相关个股有Ekso Bionics Holdings, Inc.、Avinger, Inc.、Stevanato Group S.P.A.,振幅分别为5.59%、5.02%、3.10%。West Pharmaceutical Services, Inc.公司简介:西氏医药服务总部位于美国宾夕法尼亚州,是一家制药、生物技术和仿制药行业公司的主要供应商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223315a2460165&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223315a2460165&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4504","IE00BFXG0V08.USD","WST","IE00BYQQ9H92.USD","IE00B64QTZ34.USD","BK4121","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159151157","title":"异动解读 | 西药公司2025年业绩预期大跌,股价盘中暴跌23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159151157","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159151157?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:39","pubTimestamp":1739457562,"startTime":"0","endTime":"0","summary":"西药公司今日盘中股价大跌23.14%,引发市场广泛关注。公司公布的2025年业绩预期大幅低于市场预期,成为导致股价暴跌的主因。西药公司解释称,业绩预期不佳主要是受到美元走强以及生物科技客户去库存行为的影响。疫情期间,西药公司的生物技术客户曾因供应链中断而大量囤积库存,但现在需求下降令公司业绩承压。此外,专有产品业务去年第四季度同比增长放缓,也对全年业绩造成一定冲击。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511526638","title":"West Pharmaceutical Services, Inc.盘中异动 急速下挫23.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511526638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511526638?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:33","pubTimestamp":1739457186,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时33分,West Pharmaceutical Services, Inc.股票出现异动,股价快速跳水23.98%。West Pharmaceutical Services, Inc.股票所在的医疗设备行业中,整体跌幅为0.52%。其相关个股中,Avinger, Inc.、Predictive Oncology Inc.、中进医疗涨幅较大,Avinger, Inc.、Sharps Technology Inc.、Glucotrack, Inc.较为活跃,换手率分别为351.90%、8.96%、1.41%,振幅较大的相关个股有Avinger, Inc.、Sharps Technology Inc.、AtriCure,振幅分别为8.89%、6.70%、6.28%。West Pharmaceutical Services, Inc.公司简介:西氏医药服务总部位于美国宾夕法尼亚州,是一家制药、生物技术和仿制药行业公司的主要供应商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223306a244aba1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223306a244aba1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B64QTZ34.USD","WST","IE00BYQQ9H92.USD","BK4504","BK4567","BK4585","IE00BFXG0V08.USD","BK4588","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149588111","title":"异动解读 | 西药公司业绩预期大失所望,股价暴跌近20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149588111","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149588111?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:20","pubTimestamp":1739456423,"startTime":"0","endTime":"0","summary":"在本周四的盘前交易中,西药公司(WST)的股价暴跌了19.95%,引发了市场的广泛关注。\n\n根据公司发布的信息,导致股价大跌的主要原因是公司公布的2025年业绩预期大幅低于市场预期。公司预计全年收入在28.8亿到29.1亿美元之间,中位值低于分析师预期的30.4亿美元;同时全年每股盈利预期在6美元到6.2美元之间,也远低于预期的7.44美元。\n\n公司解释称,业绩预期不佳的原因主要是美元走强,以及客户继续在去库存的影响。据悉,在新冠疫情期间,西药公司的生物科技客户曾大量囤积库存,导致近期需求下滑,对公司业绩造成了一定的压力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 西药公司业绩预期大失所望,股价暴跌近20%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WST"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.westpharma.com","stockEarnings":[{"period":"1week","weight":0.0333},{"period":"1month","weight":0.1175},{"period":"3month","weight":0.1695},{"period":"6month","weight":0.305},{"period":"1year","weight":0.446},{"period":"ytd","weight":0.4824}],"compareEarnings":[{"period":"1week","weight":-0.0173},{"period":"1month","weight":-0.0228},{"period":"3month","weight":-0.0249},{"period":"6month","weight":0.0249},{"period":"1year","weight":0.1027},{"period":"ytd","weight":0.1029}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"West Pharmaceutical Services, Inc.根据宾夕法尼亚州的法律于1923年7月27日成立。该公司是设计和生产技术先进,高质量,集成化的用于注射药物和保健产品的密封和输送系统的全球领先制造商。该公司的产品包括各种初级包装,容纳解决方案,重构和转移系统,药物输送系统,以及合同制造,分析实验室服务和集成解决方案。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.008018},{"month":2,"riseRate":0.543478,"avgChangeRate":0.003142},{"month":3,"riseRate":0.586957,"avgChangeRate":0.021659},{"month":4,"riseRate":0.595745,"avgChangeRate":0.040483},{"month":5,"riseRate":0.553191,"avgChangeRate":0.00339},{"month":6,"riseRate":0.574468,"avgChangeRate":0.019809},{"month":7,"riseRate":0.574468,"avgChangeRate":0.01064},{"month":8,"riseRate":0.617021,"avgChangeRate":0.008226},{"month":9,"riseRate":0.489362,"avgChangeRate":-0.000382},{"month":10,"riseRate":0.574468,"avgChangeRate":0.00774},{"month":11,"riseRate":0.680851,"avgChangeRate":0.016305},{"month":12,"riseRate":0.673913,"avgChangeRate":0.026146}],"exchange":"NYSE","name":"West Pharmaceutical Services Inc","nameEN":"West Pharmaceutical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"West Pharmaceutical Services Inc(WST)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供West Pharmaceutical Services Inc(WST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"West Pharmaceutical Services Inc,WST,West Pharmaceutical Services Inc股票,West Pharmaceutical Services Inc股票老虎,West Pharmaceutical Services Inc股票老虎国际,West Pharmaceutical Services Inc行情,West Pharmaceutical Services Inc股票行情,West Pharmaceutical Services Inc股价,West Pharmaceutical Services Inc股市,West Pharmaceutical Services Inc股票价格,West Pharmaceutical Services Inc股票交易,West Pharmaceutical Services Inc股票购买,West Pharmaceutical Services Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"West Pharmaceutical Services Inc(WST)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供West Pharmaceutical Services Inc(WST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}